Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
29900 | 145 | 36.2 | 57% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
554 | 13833 | CEREBRAL ISCHEMIA//SPREADING DEPRESSION//ISCHEMIC TOLERANCE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CLOMETHIAZOLE | Author keyword | 15 | 51% | 14% | 21 |
2 | CHLORMETHIAZOLE | Author keyword | 11 | 40% | 14% | 21 |
3 | CHLOMETHIAZOLE | Author keyword | 2 | 67% | 1% | 2 |
4 | AR R008055 | Author keyword | 1 | 100% | 1% | 2 |
5 | CIDE B | Author keyword | 1 | 50% | 1% | 1 |
6 | CONVULSIVE BEHAVIOR | Author keyword | 1 | 50% | 1% | 1 |
7 | MODEL OF STROKE | Author keyword | 1 | 50% | 1% | 1 |
8 | PHARMACEUT PRECLIN DEV | Address | 1 | 50% | 1% | 1 |
9 | TRIAL IMPLEMENTATION | Author keyword | 1 | 50% | 1% | 1 |
10 | CARDIOEMBOLIC INFARCTION | Author keyword | 0 | 33% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CLOMETHIAZOLE | 15 | 51% | 14% | 21 | Search CLOMETHIAZOLE | Search CLOMETHIAZOLE |
2 | CHLORMETHIAZOLE | 11 | 40% | 14% | 21 | Search CHLORMETHIAZOLE | Search CHLORMETHIAZOLE |
3 | CHLOMETHIAZOLE | 2 | 67% | 1% | 2 | Search CHLOMETHIAZOLE | Search CHLOMETHIAZOLE |
4 | AR R008055 | 1 | 100% | 1% | 2 | Search AR+R008055 | Search AR+R008055 |
5 | CIDE B | 1 | 50% | 1% | 1 | Search CIDE+B | Search CIDE+B |
6 | CONVULSIVE BEHAVIOR | 1 | 50% | 1% | 1 | Search CONVULSIVE+BEHAVIOR | Search CONVULSIVE+BEHAVIOR |
7 | MODEL OF STROKE | 1 | 50% | 1% | 1 | Search MODEL+OF+STROKE | Search MODEL+OF+STROKE |
8 | TRIAL IMPLEMENTATION | 1 | 50% | 1% | 1 | Search TRIAL+IMPLEMENTATION | Search TRIAL+IMPLEMENTATION |
9 | CARDIOEMBOLIC INFARCTION | 0 | 33% | 1% | 1 | Search CARDIOEMBOLIC+INFARCTION | Search CARDIOEMBOLIC+INFARCTION |
10 | GAMMA AMINOBUTYRIC ACID SYNTHESIS | 0 | 33% | 1% | 1 | Search GAMMA+AMINOBUTYRIC+ACID+SYNTHESIS | Search GAMMA+AMINOBUTYRIC+ACID+SYNTHESIS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHLORMETHIAZOLE | 7 | 27% | 17% | 24 |
2 | ENTRE STRUCTURE CHIMIQUE | 1 | 100% | 1% | 2 |
3 | QUELQUES DERIVES THIAZOLIQUES | 1 | 100% | 1% | 2 |
4 | CLOMETHIAZOLE | 1 | 21% | 3% | 5 |
5 | GABAA RECEPTOR COMPLEX | 0 | 10% | 3% | 4 |
6 | CLOMETHIAZOLE ACUTE STROKE | 0 | 13% | 2% | 3 |
7 | SPECTRUM ANTICONVULSANT LORECLEZOLE | 0 | 33% | 1% | 1 |
8 | AGONIST MUSCIMOL | 0 | 10% | 2% | 3 |
9 | YOUNG HEALTHY SUBJECTS | 0 | 25% | 1% | 1 |
10 | PDE9 INHIBITOR PF 04447943 | 0 | 20% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Gamma aminobutyric acid (GABA) receptor agonists for acute stroke | 2013 | 4 | 26 | 50% |
The pharmacology of chlormethiazole: A potential neuroprotective agent? | 2004 | 14 | 45 | 73% |
GABA potentiation: a logical pharmacological approach for the treatment of acute ischaemic stroke | 2000 | 105 | 97 | 24% |
Clomethiazole (Zendra (R)) in acute ischemic stroke: Basic pharmacology and biochemistry and clinical efficacy | 1998 | 26 | 197 | 15% |
INTRAVENOUS CHLORMETHIAZOLE | 1993 | 0 | 26 | 81% |
The attenuation of kainate-induced neurotoxicity by chlormethiazole and its enhancement by dizocilpine, muscimol, and adenosine receptor agonists | 1997 | 19 | 86 | 14% |
Techniques for examining neuroprotective drugs in vivo | 1997 | 12 | 60 | 13% |
THE NEUROPROTECTIVE ACTIONS OF CHLORMETHIAZOLE | 1994 | 14 | 125 | 14% |
Modulating nitric oxide signaling in the CNS for Alzheimer's disease therapy | 2013 | 0 | 170 | 5% |
Gateways to Clinical Trials | 2002 | 1 | 52 | 2% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHARMACEUT PRECLIN DEV | 1 | 50% | 0.7% | 1 |
2 | PKPD SECT | 0 | 33% | 0.7% | 1 |
3 | COMPARAT COGNIT TEAM | 0 | 10% | 1.4% | 2 |
4 | DMPKBAC | 0 | 13% | 0.7% | 1 |
5 | ANAESTHESIA NEUROINTENS CARE | 0 | 100% | 0.7% | 1 |
6 | NEUROL MAUBEUGE | 0 | 100% | 0.7% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000196437 | VINCONATE//DELAYED NEURONAL DEATH//GERBIL |
2 | 0.0000184474 | LUBELUZOLE//KR 31378//AGROPHARMA |
3 | 0.0000170660 | CNS 7056//CAS 76 75 5//PHYSIOLOGIC MODELS |
4 | 0.0000151239 | NXY 059//INTRAUTERINE ISCHEMIA//ADV MAGNET ONANCE |
5 | 0.0000125356 | ALCOHOL WITHDRAWAL SYNDROME//DELIRIUM TREMENS//ALCOHOL WITHDRAWAL DELIRIUM |
6 | 0.0000089479 | CO PROXAMOL//DEXTROPROPOXYPHENE//POISONS CENTRES |
7 | 0.0000083760 | EXPERIMENTAL THROMBOEMBOLISM//MIDDLE CEREBRAL ARTERY OCCLUSION//INTRALUMINAL SUTURE |
8 | 0.0000083574 | REMACEMIDE//LOSIGAMONE//REMACEMIDE HYDROCHLORIDE |
9 | 0.0000062643 | VINPOCETINE//VA 045//CAS 42971 09 5 |
10 | 0.0000060397 | ANOXIA AGLYCEMIA//NA CA2 CHANNEL BLOCKER//NS 7 |